Menopause research in Latin America

Area of Science:

• Reproductive Health
• Endocrinology
• Public Health in Latin America

Background:

• The Collaborative Group for Research of the Climacteric in Latin America (REDLINC) has researched climacteric topics for 15 years.
• Key areas include menopause age, metabolic syndrome, quality of life, sexual dysfunction, sleep disorders, and menopausal hormone therapy (MHT) use.

Purpose of the Study:

• To present key findings from 15 years of REDLINC research on women's health in the climacteric period in Latin America.
• To highlight regional data on menopause, metabolic syndrome, and MHT utilization.

Main Methods:

• Longitudinal research conducted over 15 years by the REDLINC network.
• Data collection on various health parameters in the general population and among gynecologists in Latin America.

Main Results:

• Average age of menopause is 49 years; metabolic syndrome prevalence is 42.9% with a new waist circumference cut-off of 88 cm for Latin American women.
• Over 50% prevalence for sexual dysfunction, poor quality of life, and sleep disorders, linked to obesity and sedentary lifestyles.
• Menopausal hormone therapy (MHT) use is low at 12.5%, with lack of prescription being the primary barrier; gynecologists underprescribe MHT despite personal use.

Conclusions:

• Significant health challenges exist for women in the climacteric period in Latin America, including high rates of metabolic syndrome and related conditions.
• Low utilization of menopausal hormone therapy (MHT) is a critical issue, influenced by physician prescribing habits and patient access.
• Further research and clinical practice changes are needed to address these prevalent women's health concerns in the region.